Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04319978
Other study ID # 92 (308) 4448862
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received
Last updated
Start date July 2020
Est. completion date November 2020

Study information

Verified date June 2020
Source Dow University of Health Sciences
Contact Arfa Baig, FCPS
Phone 03353046184
Email arfa_awan@live.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

TThis is a comparative clinical study which will be conducted in OMFS department of DIKIOHS, DUHS Ojha Karachi. In this study the investigators will be comparing the effect of dexamethasone on pain and edema when administered pre-operatively vs post-operatively following surgery of impacted lower 3rd molars. Time duration of this study will be 2 months. A total of 100 patients will be considered in this study which will be equally divided into two groups; group A and group B (50 in each group).Group A will receive dexamethasone 1 hour pre-operatively while group B will receive the same post-operatively. All surgeries will be performed by the same maxillofacial surgeon and duration of surgery will be around 30-45 mins.


Description:

To compare the effect of dexamethasone (IM; 8mg) administered pre-operatively versus post-operatively on pain and edema following surgical extraction of mesio-angularly impacted mandibular 3rd molars.

This is a comparative clinical study. This study will be conducted in Oral Maxillofacial Surgery department of DIKIOHS, DUHS Teaching Hospital, Ojha, Karachi, Pakistan. Time duration of this study will be 2 months. A total of 100 patients will be considered in the study (50 in each group). Sample size was calculated through OpenEpi, taking mean values of post-operative 3rd day swelling (cm) of group A (12.15±0.78), group B (13.85±0.78) [Ref #], 95% confidence interval (two sided) and 80% of the power of the test. The sample size came out to be 8 patients (4 in each group). The sampling technique is Convenience Sampling. Patients will be randomly distributed into two groups; Group A & Group B. Group A will receive dexamethasone 8mg Intra-muscularly 1 hour pre-operatively while Group B will receive the same immediately after surgery. All surgeries will be performed by the same maxillofacial surgeon and duration of surgery will be around 30-45 minutes.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date November 2020
Est. primary completion date September 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Patients coming to dental OPD of DIKIOHS, DUHS, Ojha with Mesioangular impactions

- Age of patients: 20-50 years

Exclusion Criteria:

- Patients with known co-morbidities

- Patients allergic to dexamethasone

- Patients with history of recent anti-inflammatory drug intake(NSAIDs, steroids, or antihistamines)

- Pregnant/lactating females

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dexamethasone injection
Dexamethasone is a synthetic corticosteroid. Dexamethasone is an adequate measure for reducing pain and edema in the post-operative recuperation period following 3rd molar surgery. A single dose of IM 8mg dexamethasone will be used for each patient.

Locations

Country Name City State
Pakistan Dr. Ishrat ul Ebad Khan Institute Of Health Sciences, DUHS, Ojha Karachi Sindh

Sponsors (1)

Lead Sponsor Collaborator
Dow University of Health Sciences

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Edema of face in the mandibular region edema will be assessed using a measuring tape in three facial planes (M1,M2,M3) M1: Tragus of Ear to Corner of Mouth M2: Tragus of Ear to Pogonion M3: Lateral Canthus of Eye to Angle of Mandible. Change in edema will be assessed from baseline at 1st, 3rd and 7th day post-operatively
Secondary Change in Intensity of Pain in the extracted site: Visual Analog Scale (VAS) Pain will be assessed using Visual Analog Scale (VAS). VAS is a psychometric response scale which can be used as a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. It is graded from 0 to 10; 0 indicating "No pain" while 10 indicating "excruciating/ unbearable pain" Change in the intensity of pain will be assessed from baseline to 1st, 3rd and 7th day post-operatively.
See also
  Status Clinical Trial Phase
Completed NCT06023524 - The Effectiveness of Laser Acupuncture and Standard Medication Therapy on Mandibular Post-Odontectomy Patients N/A
Completed NCT02547896 - Effectiveness of Diclofenac and Its Association to Codeine After Lower Third Molar Extraction. Phase 4
Completed NCT05684601 - Impact of 3D Intraoral Scanning on Postsurgical Evaluation of Mandibular Third Molar Surgery N/A
Completed NCT05170516 - The Effect of Saline Irrigation at Different Temperatures on Pain, Edema, and Trismus After Impacted Third Molar Surgery N/A
Completed NCT02481700 - Epidemiological Study on the Surgical Removal of Third Molars
Completed NCT05488028 - 3D Evaluation of Facial Swelling Post Impacted Lower Third Molars Surgery: RCT N/A
Completed NCT05679973 - Evaluation of the Efficacy of Polybutester Suture on Postoperative Complications in Lower Impacted Third Molar Surgery N/A
Recruiting NCT03741894 - Examination of the Prevention and Treatment Modalities of Alveolitis in Relation With Impacted Teeth Surgery Phase 4
Completed NCT06017570 - Risk Factors for Distal Caries of Second Molars Adjacent to Mandibular Impacted Third Molars N/A
Completed NCT03894722 - Effects of Polyvinylpyrrolidone Iodine on Postoperative Trismus and Swelling During Impacted Third Molar Surgery Phase 4
Completed NCT02831374 - Effectiveness of Platelet Rich Plasma in Wound Healing Phase 0
Completed NCT02837614 - Evaluation of Preoperative Submucosal Dexamethasone in Third Molar Surgery Phase 0
Completed NCT02494856 - Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in Lower Third Molar Removal Phase 4
Completed NCT02450487 - Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery Phase 4
Completed NCT05545553 - Piezosurgery and Conventional Rotary Instruments on Third Molar Surgery N/A
Recruiting NCT03619460 - Clinical Efficacy of a New Piezoelectric Technique for Wisdom Teeth Extraction N/A
Not yet recruiting NCT05143359 - Accuracy of Variables for Impacted Mandibular Third Molar Surgery N/A
Completed NCT03784638 - Comparison of Two Different Flap Designs for Bilateral Impacted Mandibular Third Molar Surgery N/A
Completed NCT03752255 - Verbal and Visual Information Techniques on Anxiety in Third Molar Surgery N/A
Active, not recruiting NCT04349579 - Evaluation of the Effects of Irrigation of the Extraction Socket With Rifamycine Phase 4